FDA Recall Terminated

This is an in vitro diagnostic product intended for use as a calibration serum in clinical chemistry assays. Randox calibration sera contain 42 analytes and are based on lyophilized human serum. The concentrations and activities are suitable for calibration of clinical chemistry assays both manually and on a wide range of automatic analyzers. Constituent concentrations are available at 2 levels.

Recall: Z-2490-2019 · Initiated July 12, 2019

Recall

Recall Number
Z-2490-2019
Event Number
83373
Firm
Randox Laboratories Ltd. 55 Diamond Road Crumlin (North) Ireland
FEI Number
1000361607
Product Code
JIX
Status
Terminated
Root Cause
Under Investigation by firm
Initiated
July 12, 2019
Terminated
June 17, 2020

Description

This is an in vitro diagnostic product intended for use as a calibration serum in clinical chemistry assays. Randox calibration sera contain 42 analytes and are based on lyophilized human serum. The concentrations and activities are suitable for calibration of clinical chemistry assays both manually and on a wide range of automatic analyzers. Constituent concentrations are available at 2 levels.

Reason

Randox Laboratories realigned RX Analyser Series calibration targets by 10% for AST and 9% for ALT in line with the Mean of All Instrument method target for the Randox Calibration Serum Level 3 (for calibrator lot 961UE onwards).

Action

Randox Laboratories Ltd. issued Urgent Medical Device Correction letter on 7/12/19 advising users of the problem, health risk and action to take: Replace all Quality Control value sheets with the revised sheets available on www.randox.com . Discuss the contents of this notice with your Medical Director. Complete and return the response form 12187-QA to [email protected] within five working days.

Distribution

Nationwide Foreign: Antigua, Aruba, Bahamas, Granada, Tobago,

Quantity

307 kits